CHTP Stock News 6.57 05/09/2014 19:32:47 Chelsea Therapeutics

New Post Public Reply Private Reply Replies (0) Message Board

May 9, 2014 at 8:32 PM

Chelsea Therapeutics International (CHTP) 6.57 $CHTP

Lifshitz & Miller Law Firm Announces Investigation of Chelsea Therapeutics International Ltd., KBR, Inc., OmniAmerican Bancorp, Inc., PokerTek, Inc., SP Bancorp, Inc. and 1st United Bancorp, Inc.
PR Newswire - 41 mins ago
Chelsea Therapeutics International Ltd.

Nasdaq stocks posting largest volume increases
AP - 2 hrs 28 mins ago
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:

Nasdaq stocks posting largest percentage increases
AP - 2 hrs 28 mins ago
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:

Most active Nasdaq-traded stocks
AP - 2 hrs 28 mins ago
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:

INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of Chelsea Therapeutics International, Ltd. and Its Board of Directors In Connection With the Sale of the Company to H. Lundbeck A/S
Business Wire - Fri May 09, 3:35PM CDT
Levi & Korsinsky is investigating the Board of Directors of Chelsea Therapeutics International, Ltd. ("Chelsea Therapeutics" or "the Company"

(NasdaqCM:CHTP) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to H. Lundbeck A/S.

Ryan & Maniskas, LLP Announces Investigation of Chelsea Therapeutics International Ltd.
PR Newswire - Fri May 09, 9:35AM CDT
Ryan & Maniskas, LLP is investigating potential claims against the board of directors of Chelsea Therapeutics International Ltd. ("Chelsea Therapeutics" or the "Company"

(NASDAQ: CHTP) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to sell the Company to H. Lundbeck A/S in a transaction valued at approximately $658 million.

Chelsea Therapeutics International Shares Up 30.1% Since SmarTrend's Buy Recommendation (CHTP)
Comtex SmarTrend(R) - Fri May 09, 9:13AM CDT
SmarTrend identified an Uptrend for Chelsea Therapeutics International (NASDAQ:CHTP) on January 15th, 2014 at $5.03. In approximately 4 months, Chelsea Therapeutics International has returned 30.12% as of today's recent price of $6.55.

Newman Ferrara LLP Announces Investigation of Chelsea Therapeutics International Ltd.
Business Wire - Fri May 09, 9:08AM CDT
Newman Ferrara LLP is investigating potential claims against the board of directors of Chelsea Therapeutics International ("Chelsea"

(Nasdaq: CHTP) concerning the proposed sale of Chelsea to Danish corporation H. Lundbeck A/S ("Lundbeck"

.

Law Offices of Marc S. Henzel Announces Securities Class Action Periods
PR Newswire - Fri May 09, 8:11AM CDT
The Law Offices of Marc S. Henzel (www.henzellaw.com) a firm focusing on shareholder litigation, gives notice to purchasers of the following securities for the following class periods:

Chelsea Therapeutics International Ltd. (CHTP) Looks Strong as Stock Shoots up 31.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri May 09, 7:44AM CDT
Chelsea Therapeutics International Ltd. (CHTP) was a big mover last session, as the company saw its shares soar 31.6% on the day.

SHAREHOLDER ALERT: Brower Piven Announces the Investigation of Chelsea Therapeutics International, Ltd. in Connection with the Proposed Sale of the Company to H. Lundbeck A/S
Business Wire - Thu May 08, 8:00PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty to current shareholders of Chelsea Therapeutics International, Ltd. ("Chelsea" or the "Company"

(NasdaqCM: CHTP) and other violations of state law by the board of directors of Chelsea relating to the proposed buyout of the Company by H. Lundbeck A/S ("Lundbeck"

.

CHELSEA THERAPEUTICS ALERT: Johnson & Weaver Investigating the Proposed Sale of Chelsea Therapeutics International, Ltd.
Business Wire - Thu May 08, 7:45PM CDT
Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of Chelsea Therapeutics International, Ltd. (NASDAQ: CHPT) breached their fiduciary duties in connection with the proposed sale of the Company to H. Ludbeck A/S.

Why Groupon, CenturyLink, and Chelsea Therapeutics Jumped Today
Dan Caplinger, The Motley Fool - Motley Fool - Thu May 08, 7:05PM CDT
On Thursday, investors paid close attention to whether the stock market would rise to new record highs, as the final big push of earnings season included positive reports from some major companies. Yet in the end, broader concerns about the...

Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Chelsea Therapeutics International, Ltd. Stockholders
Business Wire - Thu May 08, 5:35PM CDT
Kirby McInerney LLP is investigating potential claims against the Board of Directors of Chelsea Therapeutics International, Ltd. ("Chelsea Therapeutics" or the "Company"

(NASDAQ: CHTP) concerning the proposed acquisition of the Company by H. Lundbeck A/S ("Lundbeck"

. Under the terms of the definitive merger agreement, Chelsea Therapeutics stockholders will receive $6.44 in cash and up to $1.50 in Contingent Value Rights for each share of Chelsea Therapeutics owned, representing a total potential consideration of up to $658 million.

SHAREHOLDER ALERT: The Law Office of James C. Kelly Investigates Claims That the Proposed Acquisition of Chelsea Therapeutics International, Ltd. May Not Be in its Investors' Best Interests
PR Newswire - Thu May 08, 4:25PM CDT
The Law Office of James C. Kelly is investigating claims on behalf of investors of Chelsea Therapeutics International, Ltd. ("Chelsea" or the "Company"

(NASDAQ: CHTP), concerning the proposed acquisition of Chelsea by H. Lundbeck A/S ("Lundbeck"

. Chelsea shareholders seeking more information about this acquisition are advised to contact James C. Kelly at 888.643.7517 or jkelly@jckellylaw.com.

Why Chelsea Therapeutics, Keurig Green Mountain, and SolarCity Are Today's 3 Best Stocks
Sean Williams, The Motley Fool - Motley Fool - Thu May 08, 4:15PM CDT
In spite of generally positive economic data, and spending much of the day in positive territory, the broad-based S&P 500 finished the day modestly lower, dragged down by a combination of profit-taking, as well as number of high-profile...

INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of Chelsea Therapeutics International, Ltd. and Its Board of Directors In Connection With the Sale of the Company to H. Lundbeck A/S -- CHTP
PR Newswire - Thu May 08, 4:09PM CDT
Levi & Korsinsky is investigating the Board of Directors of Chelsea Therapeutics International, Ltd. ("Chelsea Therapeutics" or "the Company"

(NasdaqCM: CHTP) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to H. Lundbeck A/S.

After Yesterday's Rally of 31.60% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu May 08, 3:43PM CDT
Chelsea Therapeutics International (NASDAQ:CHTP) traded in a range yesterday that spanned from a low of $6.46 to a high of $6.60. Yesterday, the shares gained 31.6%, which took the trading range above the 3-day high of $5.25 on volume of 66.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

U.S. Court Ruling Opens Market for Cocrystal's CrysQnol™

Legal Drama Clears Market Path Well, folks, here’s a win from the trenches for Cocrystal Tech that can shake up the nutraceutical market. Kaneka's grip on the patent for their ubiquinol concoctions just got busted by the U.S. District Court. They ruled that Kaneka's claims lacked utility and enablement, essentially saying they were pitching an untested hypothesis as an...

Chef André Chiang Reimagines A Joy's Autumn Menu

The Culinary World of Chef André Chiang There's a brand-new aroma wafting through Taiwan's dining scene, and it's got Chef André Chiang's signature all over it. Partnering with A Joy, a high-end buffet restaurant, this all-star chef is giving us something worth the chatter: an autumn menu that's as much about memories as it is about taste. We're looking at flavors that...

Thermoplastic Polyimide: A $0.86 Billion Market by 2032

It's not often you get hyped about a compound with a name like 'thermoplastic polyimide,' but hold your horses—this isn't just any chemical. If you're watching markets with a sharp eye, you’ll see this thing estimated at $0.56 billion in 2026, gunning for a hefty $0.86 billion by 2032. We're talking about a solid 7.4% CAGR ride here folks, according to new data from...

WaFd and EverBank $3.9B Deal Spurs Big Bank Shift

Remember the good old days when banking was just about collecting interest? Now it's all about combining forces to bolster strength, and that's just what we're seeing with WaFd, Inc. (NASDAQ: WAFD) and EverBank Financial Corp flipping the script and shaking hands on a $3.9 billion reverse merger. Strategic Vision: A New Chapter They're calling it a 'strategic...

Early Orders Key for Custom Kids' Gifts This Season

Unwrap the Secret to Perfect Holiday Presents When it comes to giving the little ones something special for the holidays, the trick lies in timing. Not your run-of-the-mill timing, mind you—I'm talking about understanding how handcrafted, personalized toys can make or break the season. If you've ever scrambled for a last-minute gift, you know how that shaky feeling sets...

Indiana Fire Safety: The Importance of Regular Inspections

Everybody thinks of fire extinguishers as those red cans hanging quietly on walls, but there's more to them than meets the eye. In Central Indiana, these devices are a literal lifeline, and neglecting their upkeep is playing with fire—literally. What Makes Monthly Checks a Big Deal? Fire extinguishers aren't just there for decoration. They're critical safety gear. This...

Jixingfeng Advances Smart Manufacturing for Socks Market

Socks Evolve: From Feet Covers to Tech Gear Once upon a time, socks were merely foot covers, destined to vanish beneath pants and shoes. But not anymore. In the bustling halls of the sock world, Jixingfeng built up a robust repertoire of producing high-performance hosiery for a modern market that demands more than just warmth. They’ve turned socks into a tech-infused...

Ping An Climbs Sustainability Ladder, Scores A+ Rating

Sustainability Triumph for Ping An: A+ Upgrade Ping An Insurance (Group) Company of China, Ltd. is having quite the moment, snagging an A+ in the latest 2026 Sustainability Rating from Hang Seng Indexes Company. This ain't just a one-time pat on the back—it's the third year of consecutive improvement. Looks like Ping An's focus on ESG efforts is finally getting the...

CME Group Smashes FX Open Interest Record Again

Shattering Records: CME Group's Latest Milestone Well, here's a juicy nugget for your investment playbook. On September 4, 2026, CME Group proved, once again, why they're the big dog in the derivatives yard, announcing a new record in FX open interest—4,410,167 contracts! This tops the previous mark of 4,269,622 contracts set just a few months back. The futures and...

CalExitNow Fights Federal Interference in CA Elections

California's Election Integrity: A Ticking Time Bomb Strap in for a bumpy ride, folks—California might soon find its electoral process caught in a Washington whirlwind. CalExitNow, the group advocating for California's independence, is sounding alarms about looming federal interventions that could shake the state's democratic foundations. The Federal Storm Rolling In...